Literature DB >> 33973136

Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.

Yu Wang1, Geng Wang1, Jie Bai1, Ning Zhao1, Qingbo Wang1, Rui Zhou2, Gang Li1, Chaojie Hu3, Xin Li4, Kaixiong Tao1, Zefeng Xia5, Guobin Wang6.   

Abstract

BACKGROUND: This study aimed to investigate the weight-independent mechanism of sleeve gastrectomy on the relief of nonalcoholic fatty liver disease (NAFLD).
METHODS: A total of 58 obese patients who had undergone sleeve gastrostomy (SG) were recruited. Plasma levels of indole-3-acetic acid (I3A), a metabolite from gut microbiota before and after SG were investigated. In addition, we had 78 C57BL/6J mice included in the study. High-fat diet (HFD) was used to induce obesity in mice. Sleeve gastrectomy (SG) was then performed. The liver of the mice was analyzed by HE and oil red staining to study lipid accumulation. Fluorescence-activated cell sorting (FACS) analysis was performed to study the phenotype of macrophages in the liver. The levels of I3A in serum, stool, and liver were tested by ELISA. Macrophages and hepatocytes were cultured in vitro and stimulated with I3A to study the effects on differentiation and proliferation/apoptosis.
RESULTS: In human samples, I3A increased after SG and plasma I3A levels were positively correlated with liver CT values and negatively correlated with liver fat attenuation. In mice models, after surgery, the percentage of M2 macrophages significantly increased in the liver. Both oral gavage and in vitro stimulation of I3A could promote M2 differentiation and did not significantly affect the state of hepatocytes.
CONCLUSIONS: This study suggested that increased I3A from the intestine after SG could reduce the M1/M2 ratio in the liver and thus promote relief of NAFLD in obese individuals. Graphical Abstract.

Entities:  

Keywords:  C57BL/6J mice; Indole-3-acetic acid; Kuppffer cells; NAFLD; Sleeve gastrectomy

Year:  2021        PMID: 33973136     DOI: 10.1007/s11695-021-05321-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  36 in total

1.  Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.

Authors:  Rinki Murphy; Peter Tsai; Mia Jüllig; Amy Liu; Lindsay Plank; Michael Booth
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

2.  Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study.

Authors:  Efstathios Dimitriadis; Markos Daskalakis; Marilena Kampa; Anastasia Peppe; John A Papadakis; John Melissas
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

3.  Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis.

Authors:  Keith M Wirth; Adam C Sheka; Scott Kizy; Ryan Irey; Ashley Benner; Gretchen Sieger; Gyorgy Simon; Sisi Ma; John Lake; Constantin Aliferis; Daniel Leslie; Schelomo Marmor; Sayeed Ikramuddin
Journal:  Ann Surg       Date:  2020-07       Impact factor: 12.969

Review 4.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

Review 5.  Mechanisms of NAFLD development and therapeutic strategies.

Authors:  Scott L Friedman; Brent A Neuschwander-Tetri; Mary Rinella; Arun J Sanyal
Journal:  Nat Med       Date:  2018-07-02       Impact factor: 53.440

6.  Interventions for the management of obesity in people with bipolar disorder.

Authors:  Agnes Tully; Siobhan Smyth; Yvonne Conway; John Geddes; Declan Devane; John P Kelly; Fionnuala Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-07-20

7.  Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut-brain communication.

Authors:  L A Ballsmider; A C Vaughn; M David; A Hajnal; P M Di Lorenzo; K Czaja
Journal:  Neural Plast       Date:  2015-02-03       Impact factor: 3.599

8.  FXR is a molecular target for the effects of vertical sleeve gastrectomy.

Authors:  Karen K Ryan; Valentina Tremaroli; Christoffer Clemmensen; Petia Kovatcheva-Datchary; Andriy Myronovych; Rebekah Karns; Hilary E Wilson-Pérez; Darleen A Sandoval; Rohit Kohli; Fredrik Bäckhed; Randy J Seeley
Journal:  Nature       Date:  2014-03-26       Impact factor: 49.962

Review 9.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

View more
  4 in total

Review 1.  Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases.

Authors:  Charlotte Teunis; Max Nieuwdorp; Nordin Hanssen
Journal:  Metabolites       Date:  2022-06-02

Review 2.  Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis.

Authors:  Jiezhong Chen; Luis Vitetta; Jeremy D Henson; Sean Hall
Journal:  Int J Tryptophan Res       Date:  2022-02-07

Review 3.  Bile acids, gut microbiota and metabolic surgery.

Authors:  Jui Tu; Yangmeng Wang; Lihua Jin; Wendong Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

Review 4.  Gut Microbiota Regulation of AHR Signaling in Liver Disease.

Authors:  Baohong Wang; Ziyuan Zhou; Lanjuan Li
Journal:  Biomolecules       Date:  2022-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.